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Thus, clinical evidence is often shaped by non-randomized studies exploiting multivariable
approaches to limit the extent of confounding. Since their introduction, propensity scores have
been used more and more frequently to estimate relevant clinical effects adjusting for
established confounders, especially in small datasets. However, debate persists on their real
usefulness in comparison to standard multivariable approaches such as logistic regression and
Cox proportional hazard analysis. This holds even truer in light of key quantitative
developments such as bootstrap and Bayesian methods. This qualitative review aims to
provide a concise and practical guide to choose between propensity scores and standard
multivariable analysis, emphasizing strengths and weaknesses of both approaches.
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tools rather than from new doctrines
Freeman Dyson1. Introduction: meet the bias
Clinical decision making is based on the appraisal of
causality. In other words, we choose a given treatment
instead of another one only if we are reasonably convinced
that using it will cause speciﬁc effects (hopefully favorable
ones) on our individual patient [1]. All statistical analyses
are best viewed in this framework of causality assessment.
Indeed, evidence of a statistically signiﬁcant association (in
frequentist terms) or highly probable association (in
Bayesian terms) is just a piece of the puzzle to ﬁnally
conclude that a given treatment or exposure is causing a
given effect (e.g. aspirin prevents recurrent myocardial
infarction events, or cigarette smoking causes lung cancer)
[2]. These key criteria have been spelled out in 1965 by Sir
Austin Bradford Hill, whose seminal paper makes an
interesting reading even now: analogy, biological gradient,
coherence, consistency, experiment, plausibility, speciﬁci-
ty, strength, and temporality [1]. Thus, factors having
causal effects should be clearly distinguished from vari-
ables exhibiting casual (i.e. random) association.
Whenever a treatment or a preventive means has a
dramatic impact on outcomes, no statistical analysis is usually
needed. A small case series or small cohort (i.e. group of
patients followed thoroughly over time to capture retrospec-
tively or prospectively outcomes of interest) usually sufﬁce in
such cases. For instance, few would argue against using a
parachute when jumping out of an airplane high in the sky or
administering systemic antibiotics in a patient with acute
infective endocarditis [3]. However, most treatment alterna-
tives in current clinical practice are unlikely to cause huge
effects in a single individual. We must thus rely on large
sample sizes and appraise mild or moderate effects. This was
the reason behind the ﬁrst formal randomized clinical trial
conducted by the Streptomycin Tuberculosis Trials Commit-
tee in the 1940s [4], which aimed to appraise the role of
antimycobacterials in patients with tuberculosis, typically a
disease with low response rates occurring during long and
variable periods of time. Randomized clinical trials, alone or
combined with systematic reviews and meta-analyses, are
the uppermost ladder in the hierarchy of evidence based
medicine, and the vast majority (if not all) clinical decisions
should be based on the integration of their results with the
individual practice of medicine (thus encompassing cost and
patient values) [5]. Unfortunately, randomized clinical trials
might not be available at all to guide a speciﬁc diagnostic or
treatment choice, or they might be of low internal or external
validity. Speciﬁcally, their ﬁndings might be biased by issues
in patient selection, subject attrition, event adjudication, or
therapeutic performance.
Thus, we often rely on observational studies, mostly
retrospective or based on administrative datasets, but also not
uncommonly prospective studies (i.e. registries). However,
extracting credible results from such studies requires sophis-
ticated statistical methods, as univariate and bivariate analyses
cannot adjust effect estimates taking into account confounding
factors. A hypothetical example highlighting the issue of biasand confounding is the following. A cohort of apparently
healthy subjects is followed prospectively over 20 years in
order to identify risk factors for lung cancer. Bivariate analysis
apparently demonstrates a statistically signiﬁcant association
between thenumberofmatches (suchas those required to light
a cigarette) used by study participants over the years and the
risk of lung cancer. Is such a “demonstration” of statistical
signiﬁcance convincing enough for us toban the sale ofmatches
nationwide to reduce the incidence of lung cancer? Further
careful analysis shows actually that another variable, i.e.
cigarette smoking, is also strongly associated with lung cancer.
By appraising the independent impact ofmatches on the risk of
lung cancer while simultaneously adjusting for cigarette
smoking, we recognize that the apparent association between
matches and lung cancer was only due to the biasing effect of a
confounding factor (namely cigarette smoking).
Our present work aims to provide a concise review of
current methods to performmultivariable analysis in order to
adjust for the role of such covariates when estimating effects
of risk factors or interventions, with a particular emphasis on
a key recent item in the biostatistical armamentarium,
propensity scores. The reader should however bear in mind
that dozens of forms of bias can undermine a clinical study,
and multivariable methods cannot take into account all of
them as well as other unknown confounders, as they can only
adjust for what is accurately measured and explicitly forced
into the multivariable model [6].
2. Scope of multivariable approaches
Multivariable analysis aims to explore the relationship
between a dependent variable (e.g. risk of death) and two or
more independent variables (a.k.a. moderators, covariates, or
factors; e.g. age and serum cholesterol level) appraised
simultaneously. Thus, they estimate the independent impact
of a given covariate on the dependent variable, by concom-
itantly adjusting for the contributions of all the other
covariates present in the predictive model. Hundreds of
examples of multivariable analyses are permeating clinical
practice. For instance, the Framingham Heart Study and the
Framingham Heart Score are largely based on multivariable
logistic regression and Cox proportional hazard models [7].
Several types of multivariable analysis are available, from
stratiﬁcation and matching, to simple linear models to predict
blood pressure or highly complex hierarchical (i.e. mixed-
effect) models taking into account multiple levels and clusters
in the data (Table 1). Speciﬁcally, matching and stratiﬁcation
have been historically the ﬁrst methods to adjust for con-
founders, given the shortage of computational resources up to a
few decades ago. However, they are signiﬁcantly limited in
their robustness and applicability by the fact that both
stratiﬁcation andmatching can be performed only on a handful
of covariates, thus being impractical whenever we have more
than 4–5 confounders to take care of. Whereas discriminant
analysis has also been historically crucial in the identiﬁcation of
independent predictors of events, such as for the seminal Norris
coronary prognostic index [8], it is nowadays seldom used
because of limitations in modeling capabilities, including
appraisal of overall performance and interactions. Classiﬁcation
and regression tree (CART) analyses have similar strengths and
weaknesses in comparison to discriminant analysis, but they
Table 1
Selected approaches to perform multivariable analysis.
Method Key features
Bayesian methods Computation-intensive methods able to generate posterior probability distributions appraising multiple parameters from
simple as well as highly complex models using Markov chain Monte Carlo techniques (MCMC). Occasionally used.
Implementation requires considerable expertise in Bayesian statistical methods and programming in WinBUGS or similar
software packages.
Bootstrap Computation-intensive resampling technique with replacement making no assumptions regarding underlying population
distribution, able to generate inferences from simple as well as highly complex datasets. Usually combined with a standard
multivariable approach such as logistic regression or Cox analysis. Occasionally used. Implementation requires considerable
expertise in R or similar software packages.
Classiﬁcation and regression
tree (CART)
A recursive partitioning statistical method which builds classiﬁcation and regression trees for predicting continuous
dependent variables (regression) and categorical predictor variables (classiﬁcation). Rarely used. Implementation requires
some expertise in SPSS or similar software packages.
Cox proportional hazard
analysis
A parametric statistical method to perform survival analysis including censored data and adjusting for covariates. Several
assumptions must be met for valid results, including an event per variable ratio N8–10 and proportionality of hazard over
time. Frequently used. Implementation requires some expertise in SPSS or similar software packages.
Discriminant analysis A statistical technique to determine the class of an observation based on a set of variables known as predictors or input
variables. Rarely used. Implementation requires some expertise in SPSS or similar software packages.
Exact methods Computation-intensive methods to approximate the exact probability of a given statistical model, irrespective of its
complexity, by means of Monte Carlo procedures. Rarely used. Implementation requires considerable expertise in SAS or
similar software packages.
Instrumental variable
analysis
Econometric method used to remove the effects of hidden bias in observational studies, based on two key characteristics: it
is highly correlated with treatment and does not independently affect the outcome, so that it is not associated with
measured or unmeasured patient health status. Rarely used. Implementation requires substantial expertise in Stata or
similar software packages.
Logistic regression A parametric statistical method to appraise the impact of independent variable(s) on a categorical dependent variable.
Binary logistic regression is most commonly used in clinical research and focuses on a dichotomous dependent variable.
Several assumptions must be met for valid results, including an event per variable ratio N8–10 and lack of collinearity or
overﬁtting. Frequently used. Implementation requires some expertise in SPSS or similar software packages.
Matching A method to combine one case with one or more controls selected according to speciﬁc matching criteria (e.g. difference in
age b5 years) in order to adjust for key confounders. A major limitation is that it can usually be employed only for a few
variables, as matching subsets increase exponentially in keeping with the number of matching factors (e.g., with n
dichotomous matching variables, the ﬁnal number of matching subsets is equal to 2n). Occasionally used. Implementation of
simple matching requires some expertise in Excel or similar spreadsheets, but more complex matching procedures require
more sophisticated softwares and skills.
Mixed-effect methods A statistical method to appraise a hierarchical model combining ﬁxed and random-effect relationships between variables
and enabling also the appraisal of complex clusters in the dataset. It is usually based on a generalized linear model with
speciﬁc link functions. Occasionally used. Implementation requires considerable expertise in SPSS or similar
software packages.
Propensity score A score built according to the likelihood or propensity that a given treatment has been administered to a subject according to
all pertinent covariates that inﬂuence this treatment choice. It thus acts as a proxy between treatment, confounders and,
eventually, events. Several key assumptions must be met for the propensity score to be valid, and implementation requires
combination with matching, stratiﬁcation, or regression. Frequently used. Implementation requires some
expertise in SPSS or similar software packages.
Stratiﬁcation A method to adjust an analysis by dividing the population in a given number of subsets, perform separate analyses in such
subsets, and then obtain an average estimate of effect. Major limitations are that it is feasible and meaningful only when
effects are consistent across strata, and that it can usually be employed only for few variables, as strata increase
exponentially in keeping with the number of stratiﬁcation factors. Rarely used. Implementation requires some
expertise in SPSS or similar software packages.
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clinical reader [9].
Binary logistic regression and Cox proportional hazard
analysis are currently the most commonly used multivariable
approaches in clinical research, as they provide clear guidance
to identify predictors of binary outcomes such as death or
rehospitalization, if a number of key assumptions are met. In
addition, they maintain the ﬂexibility for complex modeling of
interaction terms and also the capability to appraise predictive
power, discrimination (e.g. by means of c-statistic, i.e. area
under the curve [AUC] of the receiver operator characteristic
[ROC]), and calibration (e.g. by means of goodness of ﬁt tests)
[10–12].
A major advancement in the ﬁeld of multivariable analysis
has been the introduction in 1983 by Rosenbaum and Rubin of
propensity scores, which can be deﬁned as the conditionalprobability of being treated given the covariates [13]. Indeed,
after having modeled the distribution of the treatment
indicator variable given the observed covariates, the ensuing
propensity score can be used to reduce selection bias through
matching, stratiﬁcation (i.e. subclassiﬁcation), regression ad-
justment, or some combination of all three [14]. Propensity
scores have recently become very successful among clinical
researchers (Fig. 1), as they are proposed more andmore often
as the gold standard multivariable approach to adjust for
selection bias and ensuing confounders in non-randomized
studies.
Other more challenging methods which may help in the
development or validation of complex statistical models
include bootstrap [15,16], and other resampling approaches
based on Monte Carlo simulations (which are however not
per se alternatives to propensity scores) [17], exact logistic
Fig. 1. Exponential increase in publications indexed in MEDLINE/PubMed
and reporting on or exploiting propensity scores for multivariable adjust-
ment. PubMed queried on 29May 2010 with the following string: propensity
AND (score* OR match*).
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analyses [21]. Nonetheless, such approaches have so far been
used less commonly in clinical research and further reﬁne-
ments in statistical methods and user-friendliness are needed
to foster their wider adoption.
Despite the availability of so many different approaches, no
single method in itself can be considered perfect or immune
from key drawbacks [22]. In addition, as all such methods are
usually applied in datasets stemming from ﬁnite samples with
limited size (e.g. b2000patients,b100 events, and/or excluding
direct population estimates). Thus, only similar results from
subsequent independent studies can effectively provide proof
of external validity [5].
3. Standard multivariable analysis
Binary logistic regression is a statistical technique exploiting
the logit function, deﬁned as the ln(p/[1-p]), where ln is the
natural logarithm and p is the probability of an event [10]. The
logit function transforms a dependent variable ranging be-
tween 0 and 1 such as a probability of an event (e.g. the
probability of dying after an acutemyocardial infarction) into a
variable stemming from −∞ to +∞. Thus, event probabilities
can be appraised as a linear regression function in order to
appraise the logit of the probability of an event (dependent
variable) givenoneormore dependent variables (e.g. age of the
patient, presence of diabetes mellitus, or usage of a novel
coronary drug or device). In other words, binary logistic
regression is a formidable tool to appraise multivariate pre-
dictors of dichotomous events, and evaluate the independent
predictive role of one ormore independent variables of interest
[16]. Binary logistic regression is commonly used and reported
in non-randomized trials, but possibly maintains a role also in
small-size randomized clinical trials, to adjust for confounders
[23]. Yet, the reader should bear inmind that logistic regression
is different from linear regression and usually covariate
adjustment does not necessarily increase power with control
of covariates in such pilot randomized trials [23].
Despite such strengths, logistic regression should not be
used or interpreted naively, as a number of key assumptions
must be met to ensure that its results are valid [10]. First, anoverﬁt model can be highly predictive in the dataset in which
the model was developed, but not in one in which it is
validated or tested. Multicollinearity, whereby covariates
present in the model are unduly associated (e.g. Pearson
correlation coefﬁcient N0.9 or b−0.9), can be present but
need to be controlled for in some way (e.g. interaction terms
are always collinear with their component main effects).
Outliers should not have an excessive weight on the analysis.
Matching (e.g. clustering) features should not be present
(otherwise a conditional logistic regression analysis or
generalized estimating equations should be used). Residual
variability follows a binomial distribution and what remain
unexplained leads to overdispersion. However, it is very
difﬁcult to deﬁne and interpret residuals from binary
outcome models. Finally, a crucial issue is maintaining an
event per variable ratio N8–10, as logistic regression looses
power and becomes biased whenever ≤8–10 events are
included in the dataset for each independent variable or
covariate forced in the initial model [24,25].
Variable selection for ﬁnal entry in the model is also a
pivotal aspect of model building for any multivariable analysis,
including logistic regression, and can be performed in several
ways, including automatic stepwise approaches such as the
forward or backward elimination techniques. We recommend
however to avoid in most cases automatic algorithms with
stepwise selection, but rather rely on prior epidemiologic
evidence (i.e. established association frompriorwell conducted
experimental or clinical studies) and strong associations (e.g.
pb0.10 or pb0.05 at bivariate analysis) stemming from the
speciﬁc dataset of interest [22,26]. Nonetheless,we caution that
use of arbitrary p-value cutoffs for variable selection without
appropriate consideration of scientiﬁc principles can be
problematic, particularly if there is a lot of data dredging and
variable transformation tried. P-values are also highly sensitive
to sample sizes. In addition, whenever performing a logistic
regression analysis, attention should be paid to appraise
prediction (e.g. by means of Nagelkerke R2), which quantify
the variability in thedependent variable explained solely by the
model), discrimination (e.g. by means of c-statistic, i.e. area
under the curve of the receiver operator characteristic), which
describes the probability of correctly discriminating cases from
non-cases, and calibration (e.g. bymeans of goodness ofﬁt tests
such as the Hosmer–Lemeshow test, which is however often
fraughtwith lowpower in small sample sizes and rarely rejects
the null hypothesis of good calibration) [10,22].
The other mainstay in multivariable analyses, Cox propor-
tional hazard analysis, has strengths and weaknesses similar to
logistic regression, with the notable advantage of addressing
differences in follow-up duration and censored data [11,12].
The hazard function, which forms the basis of Cox analysis, is
deﬁned as the event rate at time t conditional on survival until
time t or later. It is based on a semiparametric model whereby
the unique effect of a unit increase in a covariate is
multiplicative with respect to the hazard rate, itself inversely
proportional to the survival rate [27]. Censored patients are
exploited to compute hazards and are assumed in the Cox
model to fail at the same rate as the non-censored, but are not
supposed to survive to the next time point. Being a member of
the larger family of survival methods, Cox analysis is ideally
suited to estimate and interpret survival and hazard curves, to
compare two or more survival functions, and, in particular, to
Table 2
Key items for the correct conduct and appraisal of propensity scores.
Item Elaboration
Methods for variable
selection
Which method for variable selection
was used (e.g. non-parsimonious,
parsimonious with backward
stepwise algorithm, ….).
Event per variable ratio Whether an 8–10 event per variable
ratio could be achieved when
developing the propensity score.
Balance Whether balance on the potential
confounders included in the
propensity score model between
treatment groups has been achieved.
This particularly applies to matching
and stratiﬁcation procedures.
Collinearity Whether two or more confounders
and/or the exposure variable in the
model are highly correlated with each
other.
Continuous variable conformity
with linear gradient
Whether propensity scores follow a
linear gradient.
Interactions How interaction terms were handled,
as both inclusion of unnecessary
interactions and exclusion of
meaningful ones may bias the
propensity score.
Assessment of
model ﬁt (calibration)
Whether the distances between the
observed (treatment—yes or no) and
the predicted outcome from the
model (propensity score) are small
and unsystematic. This is usually
formally appraised with the Hosmer–
Lemeshow goodness of ﬁt test.
Discrimination of model How well the predicted probabilities
derived from the model classify
patients into their actual treatment
group. This is usually quantiﬁed with
c-statistic, receiver operator
characteristic, and area under the
curve.
Adjustment method How the propensity score is employed
to adjust for confounders: matching,
stratiﬁcation into quantiles (e.g.
quintiles), or regression modeling.
Matching is nowadays considered the
most effective means.
Matching method Which speciﬁc matching approach
was employed.
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controlling for covariates and known confounders. However,
the relationship between hazard rate (inherently conditional)
and survival rate (inherently unconditional) remains compli-
cated. Indeed, a hazard function is a statisticalmodel describing
the relationship between instantaneous hazard probability
conditionally to the events at previous time points. Moreover,
in addition to allowing time-varying covariates (i.e. predictors),
the Coxmodel may be generalized to time-varying coefﬁcients
as well. Additional key assumptions, on top of those required
for logistic regression, must be met to ensure that the Cox
model is valid. In particular, a key requirement is the
proportional hazards assumption, i.e. the assumption that
covariates multiply hazard. A simple way to check this
assumption is plotting the graph of log(− log(survival)) versus
log of survival time, whereby log is the natural or base 10
logarithm. This should result in largely parallel lines if the
hazard function is proportional. Another more general issue is
non-informative censoring. To satisfy this assumption, the
design of the study must ensure that the mechanisms giving
rise to censoring of individual subjects are not related to the
probability of an event occurring. In other words, censored and
non-censored patients should have the same chance of failure,
the chance of censoring should be independent of failure,
censored patients should be representative of those at risk at
censoring time, and censored patients should be supposed to
survive to the next time point. Finally, similarly to what applies
to logistic regression, an event per variable initially entered into
the model ratio N8–10 is required to obtain stable, unbiased,
and precise results [28,29].
4. Propensity scores
The propensity score is deﬁned as the conditional probabil-
ity of receiving an exposure or treatment given a vector of
measured covariates, and can be used to adjust for selection
bias when assessing causal effects in observational studies. In
other words, propensity scores act as a proxy between cases
and covariates inﬂuencing exposure, and thus can be used
instead of such covariates to simplify the analysis plan and
increase robustness. Use of propensity scores represents a
quasi-empirical correction strategyattempting to reducebiasof
treatment estimates in non-randomized studies [13,14,30].
Indeed, they have been referred as a “balancing variable”, i.e. a
proxy variable which may summarize different confounding
factors into a single dimension, and thus can be exploited to
achieve balance between 2 study groups. However, only
variables acting well before or shortly after the beginning of
the treatment exposure of interest should theoretically be used
to generate propensity scores (e.g. a propensity score for
coronary stenting versus balloon-only angioplasty should
include as generating variables diabetes mellitus, but not
whether or not the patient has undergone 6-month post-
procedural angiographic follow-up). Thus, the propensity score
does not usually use the outcome to identify the confounders,
while a clinical risk score does.
Table 2 shows some key steps necessary to implement or
appraise a propensity score, in keeping with recommendations
from Weitzen et al [32]. First, the best way to generate a
propensity score in our opinion is to conduct a logistic
regression in a non-parsimonious fashion by calculatingregression coefﬁcients (i.e. beta coefﬁcients) for all variables
acting well before or shortly before the beginning of treatment
exposure, and including key interaction terms. The outcome of
interest should not be included in the model, and over-
ﬁtting does not apply to this phase of the analysis. The
results of this non-parsimonious logistic regression are
then exploited to build the propensity score according to
the following formula: propensity score=1/(1+expmodel),
whereby the model has the form of alpha+beta1 *x+
beta2 *y+…+betaN*z.
Once the propensity score has been computed for each
case and its performance has been appraised in terms of
discrimination and calibration, we face the decision of how to
use this balancing variable in our analysis. Weitzen et al.
suggest that Hosmer–Lemeshow goodness of ﬁt tests and
c-statistic should not be used to appraise, respectively,
calibration and discrimination of the propensity score, as
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this proof of lack of sensitivity is by no means a lack of
speciﬁcity. We thus maintain our stance that both Hosmer–
Lemeshow goodness of ﬁt tests and c-statistic should be
routinely computed and reported whenever propensity
scores are used to appraise, respectively, calibration and
discrimination. Nonetheless, researchers should bear in mind
that if the discrimination is too good then the patients cannot
be adequately matched or stratiﬁed in the two groups.
Despite this standard approach to propensity scores, some
modiﬁcations have been recently proposed. It has been
claimed that logistic regression methods are inefﬁcient to
deﬁne propensity scores and machine learning methods (e.g.
boosted classiﬁcation and regression trees) should be used
instead [34]. Moreover, one of the foremost expert in the
ﬁeld, Peter C. Austin, has proposed to include in the variables
used to derive the propensity score also those related to the
outcome(s) of interest, in order to minimize the impact of
residual confounding [30]. In otherwords, if I am interested in
building a propensity score related to the use of drug-eluting
versus bare-metal coronary stents for restenosis prevention
in patients with coronary artery disease, I would include as
covariates to generate the propensity score even those
variables which come after my speciﬁc therapeutic choice
(e.g. performance of angiographic follow-up). However, this
shifts the focus of the propensity score from confounders
determining selection bias up to treatment choice but not
afterwards to confounders playing a role even after this event.
Moreover, this change limits the application of the same
propensity score to different outcome (i.e. dependent) variables
thatmight be related to altogether different covariates. Finally, it
may be argued that this makes propensity scores much more
similar to clinical risk scores (such as the Framingham Heart
Score or the Thrombolysis in Myocardial Infarction score).
Choosing the most appropriate way to exploit propensity
scores and incorporate them into the analysis remains
challenging, as several matching approaches are available
(e.g., with calipers of width of 0.2 of the standard deviation of
the logit of the propensity score, Mahalanobis metric
matching, or greedy matching), as well as stratiﬁcation (e.g.
in quintiles or deciles), generation of inverse probability of
selection weights, or incorporation into straightforward
regression models [14,31,34–36]. We do not favor matching
as it may discard several cases. Yet some evidence in support
of the superiority of this approach over stratiﬁcation and
regression strategies has been provided [37,38]. In particular,
at least when focusing on relative risks, matchingmay result in
less bias than stratiﬁcation on quintiles, even if stratiﬁcation on
quintiles or deciles provides more precise effect estimates [38].
It should also be borne inmind that if stratiﬁcation is employed,
each stratum should have a reasonably overlapping and
symmetric composition of patients with similar propensity
scores but treatedwithdifferent strategies. If this comparability
assumption is not met, stratiﬁcation, matching and regression
adjustment based on propensity scores may be biased and/or
imprecise.
There is also a dark side of the moon. As Rubin poignantly
stated, “it is important to keep in mind that even propensity
score methods can only adjust for observed confounding
covariates and not for unobserved ones.” [39]. In addition,
most propensity scores in published studies have been so farpoorly designed, analyzed, or reported. A comprehensive
appraisal of 44 articles published in major cardiology journals
between 2004 and 2006 and exploiting propensity scores was
recently reported [40]. In this work, 45% of the studies did not
provide adequate information on how the propensity score
matched pairs were obtained, 32% did not report whether
matching on the propensity score balanced baseline charac-
teristics between matched treated and untreated subjects in
the sample, only 9% reported appropriate means to compare
baseline characteristics, only 25% used statistical methods
appropriate for the analysis of matched data, and only 5%
described the matching method used, assessed balance in
baseline covariates by appropriate methods, and also used
appropriate statistical methods to estimate the treatment
effect and its signiﬁcance. Indeed, whenever employing
matched pairs, standard methods for non-clustered data
(including chi-squared tests, Gossett/Student unpaired
t tests, Wilcoxon rank sum tests, logistic regression, Kaplan–
Meier survival curves, or Cox regression) are inappropriate as
they fail to take into account the clustered structure of the
data. Conversely, the following methods should be used:
Gossett/Student paired t tests, Wilcoxon signed ranks tests,
McNemar test for correlated binary outcomes, conditional
logistic regression, logistic regression models based on
generalized estimating equations, or Cox proportional haz-
ards models stratiﬁed on the matched pairs [41].
Other major caveats involve the impact of missing data,
which are often present in observational studies and limit
model building by discarding several cases without complete
data or require extensive data imputation, and the combina-
tion of covariates which impact outcomes as well as those not
impacting outcomes. For instance, in an observational study
comparing coronary artery bypass grafting and percutaneous
coronary intervention for severe coronary artery disease,
propensity scores are similarly modiﬁed by a variable
impacting both on treatment choice and mortality (e.g.
insulin-dependent diabetes mellitus which fares better with
surgery but also has an unfavorable prognosis), and by a
variable with minor or no effect on mortality but strongly
associated with treatment exposure (e.g. nickel allergy,
which contraindicates coronary stenting but bears no
meaningful prognostic effect). The implications of such
similar impact on propensity scores are unclear. In any case,
a ﬁnal cautionary statement involves the clinical interpreta-
tion of propensity scores, which should never be interpreted
as clinical risk scores such as the Thrombolysis in Myocardial
Infarction score [42].
5. And the winner is…
Of course in science there is never a single winner or a
single loser. In fact, it is difﬁcult to clearly identify the best
method to adjust for confounders in non-randomized studies,
as both standard multivariable methods and propensity
scores have key limitations, and none is able to take into
account unknown confounders (Fig. 2; Table 3). It is also clear
that in many cases both approaches provide similar results
[43,44].
For instance, as a typical blow to the effort of identifying
any single method which is better than all the others, Stukel
et al. compared 4 analytic methods for removing the effects of
Table 3
Pros and cons of standard multivariable approaches and propensity scores.
Method Pros Cons
Binary logistic
regression/Cox
proportional
hazard analysis
• Established approach
with relatively
straightforward
interpretation
• Several key assumptions
must hold true (e.g. lack
of collinearity and
overﬁtting)
• Exploitable to build
clinical prediction
models and tools
• Biased and with low
power if event per
variable ratio N8–10
• Enable complex model
building approaches
and iterations
Propensity scores • Succinctly synthesize
several contributors of
confounding into a
single variable
• Application to multiple
treatment comparisons
not straightforward
• Intuitive appeal as
quasi-randomized
adjustment method
• Several key assumptions
must hold true (e.g.
acceptable
discrimination and
calibration)• Suitable even when
event per variable ratio
b8–10
• Must be combined with
other traditional
multivariable methods,
such as matching,
stratiﬁcation, or
regression
• Low power if event per
variable ratio N8–10
• Interpretation difﬁcult
and often mistaken as
risk score
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patients with acute myocardial infarction: multivariable
regression, propensity score risk adjustment, propensity-
based matching, and instrumental variable analysis were all
employed and compared [45]. Results from Cox proportional
hazards regression, propensity score risk adjustment and
propensity score matching were all similarly and strongly in
favor of cardiac catheterization. However, a different tech-
nique, instrumental variable analysis, showed a notably
weaker impact on mortality. Even instrumental variable
analysis has however its own caveats, and is actually more
suitable for policy questions than speciﬁc clinical issues.
Nonetheless, instrumental variable analysis, by attempting to
adjust for unmeasured confounders, retains a key role in
clinical research, given its superior performance in the
identiﬁcation/use of an instrument [20].
Some authors have actually suggested that propensity scores
do outperform standard multivariable methods. Martens et al.
have performed a careful simulation study comparing logistic
regression and propensity scores based on quintiles, showing
that the adjusted treatment effect in logistic regression is
usually, and even in large datasets, further away from the true
marginal treatment effect than the adjusted effect of quintiles of
propensity scores [46]. Thus, they concluded that propensity
score methods usually yield treatment effect estimates that are
closer to the true marginal treatment effect than a logistic
regression model in which all confounders are appraised.
Conversely, Cepeda et al. have conducted extensive Monte
Carlo simulations to compare logistic regression with pro-
pensity scores in terms of bias, precision, empirical coverage
probability, empirical power, and robustness when the
number of events is low relative to the number of
confounders initially entered in the model [25]. In this
very interesting and carefully conducted work, bias inFig. 2. Rationale underlying standard multivariable analysis for non-randomized stud
(top right panel), and randomized treatment allocation with ensuing bivariate analys
whereas those enclosed in dashed lines are not adjusted for. Propensity score adjustm
(e.g. when ﬁtted in regression models). Notably, only randomized treatment allo
unmeasured confounders.logistic regression decreased as the number of events per
confounder increased, whereas with the propensity score
bias decreased as the strength of the association of theies (top left panel), propensity score adjustment for non-randomized studies
is (bottom panel). Confounders enclosed in continuous lines are adjusted for,
ent for non-randomized studies can also directly appraise known confounder
cation with ensuing bivariate analysis also takes into account unknown or
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scores proved less biased, more robust, and more precise
than logistic regression when there were ≤7 events per
confounder, whereas the propensity score empirical
coverage probability decreased after ≥8 events per
confounder. This was at odds with the fact that logistic
regression had an increasing empirical coverage probabil-
ity as the number of events per confounder increased. In
conclusion, these authors found that propensity scores are
a good multivariable technique when there are ≤7 events
per confounder, but with a suboptimal (35%–60%) empir-
ical power. On the other hand, logistic regression (or Cox
proportional hazard analysis) is the ﬁrst choice approach
when there are ≥8 events per confounder.
Similarly critical results challenging the hype surrounding
propensity scores have been reported by Austin et al., who
demonstrated that propensity scores developed using ad-
ministrative data do not necessarily balance patient charac-
teristics contained in clinical studies and that measures of
treatment effectiveness were attenuated when obtained
using clinical data compared to administrative data [47].
Accordingly, Mansson et al. have showed that propensity
scores may also yield less precise and robust estimates when
applied to case–control or case–cohort studies, where there
might be artifactual effect modiﬁcation of the odds ratio by
level of propensity score [48].
It may truly appear as a paradox the fact that propensity
scores, which are probably superior to standard multivariable
methods only in small datasets, actually work better in larger
samples, yet still missing the performance of logistic
regression or Cox proportional hazard analysis. Indeed, in
small observational studies, substantial imbalances of some
covariates may be unavoidable despite thorough subclassiﬁ-
cation or matching using a sensibly estimated propensity
score [39]. Conversely, the larger the study, the smaller are
such imbalances, but the lower the statistical power of
propensity scores in comparison to standard multivariable
methods [25,49]. In conclusion, Shah et al. thoughtfully
suggested that in medio stat virtus, by reviewing 43 studies
including 78 exposure–outcome associations in which bothFig. 3. Practical algorithm for multivariable analysis of non-randomized clinical stud
use of propensity scores. However, exact analytic methods (e.g. exact logistic regr
propensity scores when there are 7 or fewer events per variable.propensity scores and traditional regression models were
used [50]. They found similar ﬁndings in 90% cases, with all
discrepancies due to a statistically signiﬁcant association at
regression analysis which was not observed with propensity
scores, whose quality of implementation was however
variable.
Our ﬁnal recommendation is thus that, whatever method
you employ, careful analysis and reporting are mandatory to
enable appropriate appraisal of the reported ﬁndings and,
whenever necessary, suitable replication. The bottom line is
also that propensity score methods are not meaningfully
superior to standard multivariable approaches when ade-
quate assumptions for logistic regression and Cox propor-
tional hazard analysis are met and, in particular, when the
event per variable ratio is N8–10 (Fig. 3).
6. Any suitable alternative?
Discussing other analytical approaches to complex infer-
ence is beyond the scope of this review, but hierarchical
(mixed-effect), exact regression, instrumental variable ana-
lyses, bootstrap, and Bayesian methods can all prove to be
powerful, precise, and robust [12,15,18,20,21]. However,
these approaches are not recommended for inexperienced
researchers, as more assumptions are usually required for
these complex methods. In addition, with the notable
exception of the distribution-free bootstrap, assumptions on
speciﬁc probability distributions complicate the application
and validation of these methods. Last but not least, routine
adoption of these analytical tools is slowed by hurdles in
programming in the suitable statistical packages.
7. Future perspective
What does the future hold for statistical methods
dedicated to non-randomized studies? Prognostication and
divination are difﬁcult tasks, but our informed guess is that
data mining packages will become more and more common,
enabling most researchers to conduct extensive analysis runs
with complex hierarchical models. Indeed, bootstrap is likelyies. The event per variable ratio is proposed as the key criterion to justify the
ession) or resampling methods (e.g. bootstrap) can also be used instead of
739G. Biondi-Zoccai et al. / Contemporary Clinical Trials 32 (2011) 731–740to becomemainstream in a few years, as several bootstrapping
routines have already been added to the last version of SPSS
(IBM, Armonk, NY, USA). Unfortunately, the incorporation of
these advanced statistical techniques in user-friendly statistical
programs may lead to further increase in inappropriate
application of certain statistical analyses. Therefore, it remains
important for not only researchers to learn appropriate
statistical techniques but also for peer reviews to identify
potential errors and recommend the correct analysis to be
performed, and for readers to maintain a vigilant and critical
stance whenever appraising non-randomized clinical studies.
A further development could be the increased user-
friendliness of statistical packages to perform Bayesian
analyses [51], which could also put into a larger context the
current debate on the comparison of propensity scores and
standard multivariable techniques, further showing that each
approach has its own pros and cons, and that both should best
be viewed as complementary rather than alternative.
8. Conclusions
Since their introduction, propensity scores have proved
beneﬁcial to adjust for confounders in small datasets of non-
randomized studies, where they clearly appear less biased,
more robust, and more precise than standard multivariable
methods. Their performance in larger datasets with at least
8–10 events per variable is similar or even worse to that
provided by logistic regression or Cox proportional hazard
analyses, as demonstrated by Cepeda et al., [25]. Awaiting
novel additional methods to adjust for known and unknown
confounders, clinical researchers should be aware that
currently available adjustment methods including propen-
sity scores (yet with the notable exclusion of instrumental
variable analysis), can only address observed confounders,
but dangerously overlook unobserved ones.
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